Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease.
Damlaj M, Alahmari B, Alaskar A, Alhejazi A, Alsadi H, Shehab-Eddine I, Alghamdi A, Almashaqbeh W, Alshobaki H, Mahasneh I, Alotaibi A, Alanazi T, Balili M, Quarshi M, Ahmed M, Alzahrani M.
Damlaj M, et al. Among authors: alotaibi a.
Bone Marrow Transplant. 2022 Feb;57(2):319-322. doi: 10.1038/s41409-021-01548-8. Epub 2022 Jan 13.
Bone Marrow Transplant. 2022.
PMID: 35022534
No abstract available.